ESC Professional Premium Access

Empirical Marshall vein ethanol infusion as the first-line strategy in patients with persistent atrial fibrillation undergoing mitral isthmus ablation

Congress Presentation

About the speaker

Doctor Xianfeng Du

The First Affiliated Hospital of Ningbo University, Ningbo (China)
0 follower

8 more presentations in this session

Optimal cutoff duration of history or persistence of atrial fibrillation to undergo radiofrequency catheter ablation of longstanding atrial fibrillation

Speaker: Doctor Y. Egami (Sakai, JP)

Thumbnail

The impact of extensive ablation strategy for persistent atrial fibrillation on left atrial function and cardiovascular events: Insights from EARNEST-PVI randomized controlled trial

Speaker: Doctor T. Oka (Suita, JP)

Thumbnail

New mapping for determination of left atrial posterior wall isolation for non-paroxysmal atrial fibrillation

Speaker: Doctor A. Suzuki (Tokyo, JP)

Thumbnail

Acute termination as an endpoint in individualised electrophysiological substrate ablation in persistent atrial fibrillation

Speaker: Doctor A. Sharp (Oxford, GB)

Thumbnail

Relationship between pre-procedural non-ischemic ST-segment depression and the clinical outcomes after catheter ablation in persistent atrial fibrillation patients

Speaker: Doctor M. Yano (Sakai, JP)

Thumbnail

Access the full session

Insights into catheter ablation of non-paroxysmal atrial fibrillation

Speakers: Doctor X. Du, Doctor Y. Egami, Doctor T. Oka, Doctor A. Suzuki, Doctor A. Sharp...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb